Guo Xiaopeng, Xing Hao, Pan Huiru, Wang Yuekun, Chen Wenlin, Wang Hai, Zhang Xin, Liu Jiahui, Xu Nan, Wang Yu, Ma Wenbin
Department of Neurosurgery, Center for Malignant Brain Tumors, and National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; China Anti-Cancer Association Specialty Committee of Glioma, Peking Union Medical College Hospital, Beijing, China.
Department of Neurosurgery, Center for Malignant Brain Tumors, and National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
World Neurosurg. 2024 Dec;192:e355-e365. doi: 10.1016/j.wneu.2024.09.105. Epub 2024 Oct 18.
This study aimed to integrate intraoperative ultrasound and magnetic resonance imaging (IMRI) with neuronavigation (NN) to create a multimodal surgical protocol for diffuse gliomas. Clinical outcomes were compared to the standard NN-guided protocol.
Adult patients with diffuse gliomas scheduled for gross total resection (GTR) were consecutively enrolled to undergo either NN-guided surgery (80 patients, July 2019-January 2022) or multimodal-integrated surgery (80 patients, February 2022-August 2023). The primary outcomes were the extent of resection (EOR) and GTR. Additional outcomes included operative time, blood loss, length of hospital stay, and patient survival.
GTR was achieved in 69% of patients who underwent multimodal-integrated surgery, compared to 43% of those who received NN-guided surgery (P = 0.002). Residual tumor was detected by IMRI in 53 patients (66%), and further GTR was achieved in 28 of these cases. The median EOR was 100% for the multimodal group and 95% for the NN-guided group (P = 0.001), while the median operative time was 8 hours versus 5 hours (P < 0.001). Neurological deficits, blood loss, and hospital stay durations were comparable between 2 groups. Multimodal-integrated surgery resulted in greater EOR and higher GTR rates in contrast-enhancing gliomas, gliomas in eloquent regions, and large gliomas (≥50 mm). GTR in glioblastomas and other contrast-enhancing gliomas contributed to improved overall survival.
Compared to standard NN-guided surgery, multimodal-integrated surgery using NN, IMRI, and intraoperative ultrasound significantly increased the EOR and GTR rates for diffuse gliomas.
本研究旨在将术中超声和磁共振成像(IMRI)与神经导航(NN)相结合,为弥漫性胶质瘤创建一种多模式手术方案。将临床结果与标准的神经导航引导方案进行比较。
计划进行全切除(GTR)的成年弥漫性胶质瘤患者连续入组,接受神经导航引导手术(80例患者,2019年7月至2022年1月)或多模式综合手术(80例患者,2022年2月至2023年8月)。主要结果是切除范围(EOR)和全切除率。其他结果包括手术时间、失血量、住院时间和患者生存率。
接受多模式综合手术的患者中有69%实现了全切除,而接受神经导航引导手术的患者中这一比例为43%(P = 0.002)。IMRI在53例患者(66%)中检测到残留肿瘤,其中28例实现了进一步的全切除。多模式组的EOR中位数为100%,神经导航引导组为95%(P = 0.001),而手术时间中位数分别为8小时和5小时(P < 0.001)。两组之间的神经功能缺损、失血量和住院时间相当。在强化胶质瘤、功能区胶质瘤和大型胶质瘤(≥50 mm)中,多模式综合手术导致更高的EOR和全切除率。胶质母细胞瘤和其他强化胶质瘤的全切除有助于提高总生存率。
与标准的神经导航引导手术相比,使用神经导航、IMRI和术中超声的多模式综合手术显著提高了弥漫性胶质瘤的EOR和全切除率。